ANDA approval received by Glenmark Pharmaceuticals for Desonide Cream, 0.05%
July 31, 2017 | Monday | News
Glenmark’s current portfolio consists of 120 products authorized for distribution in the U.S. marketplace and 65 ANDA’s pending approval with the U.S. FDA
Source: Pixabay
Glenmark Pahrmaceuticals Inc., USA has received an approval by the United States Food & Drug Administration (USFDA) for Desonide Cream, 0.05%.
It is the generic version of Desonide Cream, 0.05% of Perrigo New York Inc.
According to IMS Health sales data for the 12 month period ending May 2017, the Desonide Cream, 0.05% market1 achieved annual sales of approximately $44.6 million.
Glenmark’s current portfolio consists of 120 products authorized for distribution in the U.S. marketplace and 65 ANDA’s pending approval with the U.S. FDA.
